SEC Filings

SEC Filings

Filing date	Form	Description	Filing Group	Issuer	View
Mar 12, 2020	10-K	Annual report which provides a comprehensive overview of the company for the past year	Annual Filings	Mirum Pharmaceuticals, Inc.	0001564590-20-010471.pdf 0001564590-20-010471.rtf 0001564590-20-010471.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Aug 28, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	Mirum Pharmaceuticals, Inc.	0001564590-19-033345.pdf 0001564590-19-033345.rtf 0001564590-19-033345.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Nov 06, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	Mirum Pharmaceuticals, Inc.	0001564590-19-041030.pdf 0001564590-19-041030.rtf 0001564590-19-041030.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
May 07, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	Mirum Pharmaceuticals, Inc.	0001564590-20-022856.pdf 0001564590-20-022856.rtf 0001564590-20-022856.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Aug 06, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	Mirum Pharmaceuticals, Inc.	0001564590-20-037771.pdf 0001564590-20-037771.rtf 0001564590-20-037771.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Nov 12, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	Mirum Pharmaceuticals, Inc.	0001564590-20-053201.pdf 0001564590-20-053201.rtf 0001564590-20-053201.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Jul 17, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-19-042433.pdf 0001209191-19-042433.rtf View HTML
Jul 17, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-19-042448.pdf 0001209191-19-042448.rtf View HTML
Jul 17, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-19-042429.pdf 0001209191-19-042429.rtf View HTML
Jul 17, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	Mirum Pharmaceuticals, Inc.	0001209191-19-042442.pdf 0001209191-19-042442.rtf View HTML

Data provided by Kaleidoscope.